UK Government responds to the AI Action Plan
In January, the UK government set out its response to the AI Opportunities Action Plan that was developed by tech entrepreneur and Chair of Advanced Research and Invention Agency (ARIA) Matt Clifford CBE. The plan set out recommendations for the government, which...
Public interest prevails: Roche denied injunction in patent dispute
F. Hoffmann-La Roche AG (Roche) brought a Patent infringement case at the Delhi High Court against Natco Pharma Limited (Natco). The claim of Roche was based on infringement of its patent for a compound Risdiplam marketed under the brand name EVRYSDI® used in the...
Pfizer and BioNTech secure PTAB victory against Moderna amid global patent disputes
Pfizer and BioNTech scored a significant win at the US Patent Trial and Appeal Board (PTAB or the Board) over COVID-19 vaccine technology. The Board invalidated all challenged claims in two of Moderna's patents related to its Spikevax COVID-19 vaccine, citing strong...
Nike v. Lululemon: a landmark patent battle in the footwear industry
The ongoing legal battle between Nike and Lululemon has become a focal point in the sportswear industry, highlighting the increasing importance of intellectual property (IP) protection in a highly competitive market. The case, which began in January 2023, centers...
Open source and AI from a community-based intellectual property perspective
We recently had the opportunity to speak with Keith Bergelt, the CEO of Open Invention Network (OIN). OIN is the largest patent non-aggression community in history and the forerunner to many other organizations that have been formed to collectively shield companies...
Open Invention Network expands patent protection for largest cross-license in history
Open Invention Network (OIN) oversees the largest patent cross-license in history, with more than 3,800 participants. The cross-license covers basic software componentry across a spectrum of vertical industries that include security, networking, cloud computing,...
A novel twin-litigation strategy: how France can help sidestep the jurisdiction wrangling issue
Patent owners and implementers have struggled to litigate global FRAND rates when negotiations do not lead to a license. FRAND, the concept that a patent owner who participated in creating technical standards used by all companies in an industry should license their...
Stuff You Should Know About IP podcast: new episode out now!
CTC Legal Media is very excited to announce that, after a long hiatus, the Stuff You Should Know About IP podcast is back with a brand new episode! Hosted by Ray Guarnieri and Thomas J. Colson, episode 50 focuses on eight intellectual property challenges startups must...
USPTO on trial: patent office sued for patent infringement
The US Patent and Trademark Office (USPTO) has been sued for allegedly infringing on six patents it previously granted. The patents involved are two-factor authentication systems belonging to two individual inventors and are now being contested by Factor2 Multimedia....
Pfizer triumphs over AstraZeneca in cancer drug patent dispute
In a landmark ruling, the US District Court for the District of Delaware has ordered AstraZeneca to pay Pfizer $107.5 million in damages for infringing on patents related to the lung cancer drug 'Tagrisso.' This case marks a significant victory for Pfizer in the...
Tencent demonstrates longstanding dedication to protecting and enhancing the value of IP at INTA’s 2024 Annual Meeting
ATLANTA, GEORGIA – May 22, 2024 – At this week’s International Trademark Association (INTA) 2024 Annual Meeting, INTA partner and Meeting sponsor Tencent joined thousands of attendees in celebrating the essential role of IP in creativity, commerce, and innovation. The...
‘Squeeze argument’ in patent infringement: tamper-evident closure case
A recent judgment on 8 May 2024, by the Hon'ble High Court of Delhi, in Guala Closures SPA v. AGI Greenpac Limited sheds light on the strategic maneuver known as the 'squeeze argument' and its profound significance in patent infringement cases. This case underscores...
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
The license agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering. Dublin, Ireland, and Rome, Italy, 20 May 2024 — ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in...
UPC referendum in Ireland postponed
The Irish Government has confirmed its decision to defer the date for the referendum for the ratification of the agreement on a Unified Patent Court (UPC), which was due to be held on 7 June 2024 to coincide with the European and Local elections. No alternative date...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.